EXPRESS SCRIPTS HOLDING COMPANY (NASDAQ:ESRX) Files An 8-K Regulation FD DisclosureItem 7.01
Regulation FD Disclosure. |
| • |
unexpected costs regarding the proposed merger; |
| • |
diversion of management’s attention from ongoing business operations and opportunities; |
| • |
potential litigation associated with the proposed merger; |
| • |
the ability to retain key personnel; |
| • |
the availability of financing; |
| • |
effects on the businesses as a result of uncertainty surrounding the proposed merger; and |
| • |
the industry may be subject to future risks that are described in SEC reports filed by Express Scripts Holding Company and Cigna Corporation. |
Express Scripts Holding Co. ExhibitEX-99.1 2 d495652dex991.htm EX-99.1 EX-99.1 Express Scripts KEY FACTS FOR CIGNA INVESTORS Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication,…To view the full exhibit click here